Please wait a minute...

Frontiers of Medicine

Front. Med.    2020, Vol. 14 Issue (5) : 623-629
Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19
Zhihang Peng1, Wenyu Song1, Zhongxing Ding1, Quanquan Guan2, Xu Yang2, Qiaoqiao Xu2, Xu Wang2, Yankai Xia2()
1. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2. Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, China
Download: PDF(2034 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Coronavirus disease 2019 (COVID-19) is currently under a global pandemic trend. The efficiency of containment measures and epidemic tendency of typical countries should be assessed. In this study, the efficiency of prevention and control measures in China, Italy, Iran, South Korea, and Japan was assessed, and the COVID-19 epidemic tendency among these countries was compared. Results showed that the effective reproduction number(Re) in Wuhan, China increased almost exponentially, reaching a maximum of 3.98 before a lockdown and rapidly decreased to below 1 due to containment and mitigation strategies of the Chinese government. The Re in Italy declined at a slower pace than that in China after the implementation of prevention and control measures. The Re in Iran showed a certain decline after the establishment of a national epidemic control command, and an evident stationary phase occurred because the best window period for the prevention and control of the epidemic was missed. The epidemic in Japan and South Korea reoccurred several times with the Re fluctuating greatly. The epidemic has hardly rebounded in China due to the implementation of prevention and control strategies and the effective enforcement of policies. Other countries suffering from the epidemic could learn from the Chinese experience in containing COVID-19.

Keywords COVID-19      epidemic control comparison      Chinese experience     
Corresponding Author(s): Yankai Xia   
Just Accepted Date: 16 April 2020   Online First Date: 03 June 2020    Issue Date: 12 October 2020
 Cite this article:   
Zhihang Peng,Wenyu Song,Zhongxing Ding, et al. Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19[J]. Front. Med., 2020, 14(5): 623-629.
E-mail this article
E-mail Alert
Articles by authors
Zhihang Peng
Wenyu Song
Zhongxing Ding
Quanquan Guan
Xu Yang
Qiaoqiao Xu
Xu Wang
Yankai Xia
Fig.1  Time series of the number of newly reported, newly suspected, and newly cured cases with the time points of implementation of enhanced containment and mitigation interventions.
Fig.2  Time series of the number of newly reported cases with the time points of implementation of enhanced containment and mitigation interventions in Italy (A), Iran (B), Japan (C), and South Korea (D).
Fig.3  Comparison of the trends of the effective reproduction number of COVID-19 among the five countries.
Countries Re
Day 1 Day 29
China 2.80 0.51
Italy 3.47 8.01
Iran 3.90 7.90
South Korea 3.20 6.40
Japan 2.97 3.91
Tab.1  Summary of the effective reproduction number (Re) in the five countries
1 P Zhou, XL Yang, XG Wang, B Hu, L Zhang, W Zhang, HR Si, Y Zhu, B Li, CL Huang, HD Chen, J Chen, Y Luo, H Guo, RD Jiang, MQ Liu, Y Chen, XR Shen, X Wang, XS Zheng, K Zhao, QJ Chen, F Deng, LL Liu, B Yan, FX Zhan, YY Wang, GF Xiao, ZL Shi. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270–273 pmid: 32015507
2 T Carvalho. COVID-19 research in brief: 28 March to 3 April, 2020. Nat Med 2020. [Epub ahead of print] doi: 10.1038/d41591-020-00008-y pmid: 32246113
3 E Mahase. COVID-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ 2020; 368: m1036 pmid: 32165426
4 SGS Shah, A Farrow. A commentary on “World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)”. Int J Surg 2020; 76: 128–129 pmid: 32169574
5 YR Guo, QD Cao, ZS Hong, YY Tan, SD Chen, HJ Jin, KS Tan, DY Wang, Y Yan. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak— an update on the status. Mil Med Res 2020; 7(1): 11 pmid: 32169119
6 Y Peng, YH Zhou. Is novel coronavirus disease (COVID-19) transmitted through conjunctiva? J Med Virol 2020; jmv.25753 pmid: 32176356
7 AJ Rodriguez-Morales, JA Cardona-Ospina, E Gutiérrez-Ocampo, R Villamizar-Peña, Y Holguin-Rivera, JP Escalera-Antezana, LE Alvarado-Arnez, DK Bonilla-Aldana, C Franco-Paredes, AF Henao-Martinez, A Paniz-Mondolfi, GJ Lagos-Grisales, E Ramírez-Vallejo, JA Suárez, LI Zambrano, WE Villamil-Gómez, GJ Balbin-Ramon, AA Rabaan, H Harapan, K Dhama, H Nishiura, H Kataoka, T Ahmad, R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19) Sah. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020. [Epub ahead of print] doi: 10.1016/j.tmaid.2020.101623 pmid: 32179124
8 Z Cheng, Y Lu, Q Cao, L Qin, Z Pan, F Yan, W Yang. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. AJR Am J Roentgenol 2020. [Epub ahead of print] doi: 10.2214/AJR.20.22959 pmid: 32174128
9 S Jiang. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature 2020; 579(7799): 321 pmid: 32179860
10 A Cortegiani, G Ingoglia, M Ippolito, A Giarratano, S Einav. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020. [Epub ahead of print] doi: 10.1016/j.jcrc.2020.03.005 pmid: 32173110
11 M Ajelli, P Poletti, A Melegaro, S Merler. The role of different social contexts in shaping influenza transmission during the 2009 pandemic. Sci Rep 2015; 4: 7218 pmid: 25427621
12 F Etbaigha, A R Willms, Z Poljak. An SEIR model of influenza A virus infection and reinfection within a farrow-to-finish swine farm. PLoS One 2018; 13(9): e0202493 pmid: 30248106
13 JE Park, S Jung, A Kim, JE Park. MERS transmission and risk factors: a systematic review. BMC Public Health 2018; 18(1): 574 pmid: 29716568
14 H Nishiura, MG Roberts. Estimation of the reproduction number for 2009 pandemic influenza A(H1N1) in the presence of imported cases. Euro Surveill 2010; 15(29): 19622 pmid: 20667300
15 E Shim, A Tariq, W Choi, Y Lee, G Chowell. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis 2020; 93: 339–344 pmid: 32198088
16 LF White, J Wallinga, L Finelli, C Reed, S Riley, M Lipsitch, M Pagano. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses 2009; 3(6): 267–276 pmid: 19903209
17 J Wallinga, M Lipsitch. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 2007; 274(1609): 599–604 pmid: 17476782
18 A Cori, NM Ferguson, C Fraser, S Cauchemez. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol 2013; 178(9): 1505–1512 pmid: 24043437
19 R Nikbakht, MR Baneshi, A Bahrampour. Estimation of the basic reproduction number and vaccination coverage of influenza in the United States (2017–18). J Res Health Sci 2018; 18(4): e00427
pmid: 30728313
20 X Wang, Y Shi, Z Feng, J Cui. Evaluations of interventions using mathematical models with exponential and non-exponential distributions for disease stages: the case of Ebola. Bull Math Biol 2017; 79(9): 2149–2173 pmid: 28721471
21 Q Li, X Guan, P Wu, X Wang, L Zhou, Y Tong, R Ren, KSM Leung, EHY Lau, JY Wong, X Xing, N Xiang, Y Wu, C Li, Q Chen, D Li, T Liu, J Zhao, M Liu, W Tu, C Chen, L Jin, R Yang, Q Wang, S Zhou, R Wang, H Liu, Y Luo, Y Liu, G Shao, H Li, Z Tao, Y Yang, Z Deng, B Liu, Z Ma, Y Zhang, G Shi, TTY Lam, JT Wu, GF Gao, BJ Cowling, B Yang, GM Leung, Z Feng. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382(13): 1199–1207 pmid: 31995857
22 H Nishiura, NM Linton, AR Akhmetzhanov. Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis 2020; 93: 284–286 pmid: 32145466
23 P Zhong, S Guo, T Chen. Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China. J Travel Med 2020; 14(2): 113–116 pmid: 32181483
24 P Hunter. The spread of the COVID-19 coronavirus: health agencies worldwide prepare for the seemingly inevitability of the COVID-19 coronavirus becoming endemic. EMBO Rep 2020; 21(4): e50334 pmid: 32181577
25 G Zhou, S Chen, Z Chen. Back to the spring of 2020: facts and hope of COVID-19 outbreak. Front Med 2020; 14(2): 113–116 pmid: 32172487
26 A Remuzzi, G Remuzzi. COVID-19 and Italy: what next? Lancet 2020. [Epub ahead of print] doi: 10.1016/S0140-6736(20)30627-9
pmid: 32178769
27 E Mahase. COVID-19: outbreak could last until spring 2021 and see 7.9 million hospitalised in the UK. BMJ 2020; 368: m1071 pmid: 32179567
28 E Livingston, K Bucher. Coronavirus disease 2019 (COVID-19) in Italy. JAMA 2020. [Epub ahead of print] doi: 10.1001/jama.2020.4344 pmid: 32181795
29 MS Green. Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? Lancet 2020; 395(10229): 1034–1035 pmid: 32178767
30 The Lancet Infectious Diseases. COVID-19, a pandemic or not? Lancet Infect Dis 2020; 20(4): 383 pmid: 32178762
31 F Gong, Y Xiong, J Xiao, L Lin, X Liu, D Wang, X Li. China’s local governments are combating COVID-19 with unprecedented responses–from a Wenzhou governance perspective. Front Med 2020; 14(2): 220–224 pmid: 32166600
32 Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention; Korea Centers for Disease Control and Prevention. Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 2020; 35(10): e112 pmid: 32174069
[1] FMD-20039-OF-XYK_suppl_1 Download
Related articles from Frontiers Journals
[1] Chen Xu, Yinqiao Dong, Xiaoyue Yu, Huwen Wang, Lhakpa Tsamlag, Shuxian Zhang, Ruijie Chang, Zezhou Wang, Yuelin Yu, Rusi Long, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xinxin Zhang, Hui Wang, Yong Cai. Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios[J]. Front. Med., 2020, 14(5): 613-622.
[2] Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Fei Zhou, Yeming Wang, Jiapei Yu, Luning Yang, Ke Xie, Zhisheng Huang, Lixue Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis[J]. Front. Med., 2020, 14(5): 601-612.
[3] Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, Kaixi Liu, Alain Vuylsteke, Hongbing Xiang, Xiangyang Guo. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain[J]. Front. Med., 2020, 14(5): 533-541.
[4] Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang. Taizhou’s COVID-19 prevention and control experience with telemedicine features[J]. Front. Med., 2020, 14(4): 506-510.
[5] Guangbiao Zhou, Saijuan Chen, Zhu Chen. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies[J]. Front. Med., 2020, 14(2): 117-125.
[6] Yong Li, Fan He, Ning Zhou, Jia Wei, Zeyang Ding, Luyun Wang, Peng Chen, Shuiming Guo, Binhao Zhang, Xiaoning Wan, Wei Zhu, on behalf of Multidisciplinary Team for COVID-19, Optical Valley Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Organ function support in patients with coronavirus disease 2019: Tongji experience[J]. Front. Med., 2020, 14(2): 232-248.
[7] Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, Saijuan Chen. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions[J]. Front. Med., 2020, 14(2): 229-231.
[8] Fanghua Gong, Yong Xiong, Jian Xiao, Li Lin, Xiaodong Liu, Dezhong Wang, Xiaokun Li. China’s local governments are combating COVID-19 with unprecedented responses ---- from a Wenzhou governance perspective[J]. Front. Med., 2020, 14(2): 220-224.
[9] Shuxian Zhang, Zezhou Wang, Ruijie Chang, Huwen Wang, Chen Xu, Xiaoyue Yu, Lhakpa Tsamlag, Yinqiao Dong, Hui Wang, Yong Cai. COVID-19 containment: China provides important lessons for global response[J]. Front. Med., 2020, 14(2): 215-219.
[10] Ruijie Chang, Huwen Wang, Shuxian Zhang, Zezhou Wang, Yinqiao Dong, Lhakpa Tsamlag, Xiaoyue Yu, Chen Xu, Yuelin Yu, Rusi Long, Ning-Ning Liu, Qiao Chu, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xiaobei Deng, Jinyan Huang, Xinxin Zhang, Hui Wang, Yong Cai. Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China[J]. Front. Med., 2020, 14(2): 199-209.
[11] Li Ni, Ling Zhou, Min Zhou, Jianping Zhao, Dao Wen Wang. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19[J]. Front. Med., 2020, 14(2): 210-214.
Full text